Mar 18, 2013

Personalized Cancer Medicine project started. First samples being sequenced


We have started the sequencing of the first samples for the National Personalized Cancer Medicine project lead by the Norwegian Cancer Genomics Consortium. Approximately 200 samples from human melanoma patients will be exome sequenced using Agilent SureSelect Human All Exome V5 target enrichment technology.

We have started the sequencing of the first samples for the National Personalized Cancer Medicine project lead by the Norwegian Cancer Genomics Consortium. Approximately 200 samples from human melanoma patients will be exome sequenced using Agilent SureSelect Human All Exome V5 target enrichment technology.

 
 
 
 


News

Sep 15, 2018

The Genomics Core Facility has recently installed a NanoString nCounter system. The nCounter utilizes a novel digital barcode technology for direct multiplexed measurement of analytes and offers high levels of precision and sensitivity. This technology allows the analysis of expression of up to 800 mRNAs, miRNAs, DNA regions, or proteins simultaneously, using predesigned assays, as well as custom solutions. 

May 5, 2018
The Genomics Core Facility has recently acquired new instrumentation, the ChromiumTM(10X Genomics) and RhapsodyTM(BD Genomics) enabling Single Cell Sequencing and sequencing of Artificial Long Reads.


Contact Information:

Genomics@rr-research.no

Unit Leader Core Facility
Susanne Lorenz, PhD

Susanne.Lorenz@rr-research.no

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

Leonardo.A.Meza-Zepeda@rr-research.no

Visiting address:

Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

................................................................

................................................................